| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Molina Arturo Md serves as a Chief Medical Officer at PTGX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 16 sells. Those positions are worth an estimated $8.8M at current prices.
Historically, Molina Arturo Md's trades have earned a below-average insider score of 32/100 across 9 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -93.3%.
The biggest single holding is PTGX (~$8.8M) as Chief Medical Officer. The recent filings there lean toward selling, a net 139,814 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 14, 2020 | STRO Sutro Biopharma, Inc. | Chief Medical Officer | Buy | 6,451 | $7.75 | $49,995.25 | +114.5% |